Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

FDMTFDMT
23 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in 4D MOLECULAR THERAPEUTICS IN

GEODE CAPITAL MANAGEMENT, LLC holds 1.1M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $15M as of 2026-Q2. The position was increased (+5.9% shares). FDMT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$15M

Current Shares

1.1M

Total Value Change

+$14.5M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+5.9%
$15M0.0%$13.30
30
2026-Q1
Increased
1.1M
+5.3%
$9.9M0.0%$8.46
29
2025-Q4
Increased
1M
+10.8%
$7.6M0.0%$7.58
30
2025-Q3
Decreased
913,519
-0.6%
$7.9M0.0%$8.35
0
2025-Q2
Decreased
918,533
-4.6%
$3.4M0.0%$3.84
0
2025-Q1
Decreased
963,269
-4.8%
$3.1M0.0%$3.63
0
2024-Q4
Decreased
1M
-2.4%
$5.6M0.0%$5.30
0
2024-Q3
Decreased
1M
-2.3%
$11.2M0.0%$10.83
0
2024-Q2
Increased
1.1M
+21.6%
$22.3M0.0%$20.99
34
2024-Q1
Increased
872,663
+12.1%
$27.8M0.0%$31.86
32
2023-Q4
Increased
778,162
+4.9%
$15.8M0.0%$20.26
30
2023-Q3
Increased
741,665
+7.5%
$9.4M0.0%$12.73
30
2023-Q2
Increased
689,777
+19.4%
$12.5M0.0%$17.73
33
2023-Q1
Increased
577,922
+2.9%
$9.9M0.0%$16.75
28
2022-Q4
Increased
561,737
+6.2%
$12.5M0.0%$22.21
30
2022-Q3
Increased
528,936
+7.3%
$4.3M0.0%$8.22
29
2022-Q2
Increased
492,825
+3.0%
$3.4M0.0%$7.27
27
2022-Q1
Decreased
478,623
-0.8%
$7.2M0.0%$15.49
0
2021-Q4
Increased
482,437
+41.0%
$10.6M0.0%$21.87
37
2021-Q3
Increased
342,218
+104.4%
$9.2M0.0%$27.92
45
2021-Q2
Increased
167,434
+14.4%
$4M0.0%$23.50
30
2021-Q1
Increased
146,298
+1044.7%
$6.3M0.0%$38.55
44
2020-Q4
New
12,780
-
$529,0000.0%$41.64
33

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used